Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients

British Journal of Haematology

Volumn 140, Issue 3, 2008, Pages 340-343

  Pérez, Antonio ^a   González Vicent, Marta ^a   Ramirez, Manuel ^a   Sevilla, Julián ^a   Madero, Luis ^a   Díaz, Miguel Angel ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Acute leukaemia; Graft versus host disease; Stem cell transplantation

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD34 SELECTION; CELL THERAPY; CHILD; CHILDHOOD LEUKEMIA; CHIMERA; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; HUMAN CELL; INFANT; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTIGENS, CD3; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS LEUKEMIA EFFECT; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE TRANSFUSION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; STEM CELLS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 38349120428     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06911.x     Document Type: Article

References (14)

1. + cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. British Journal of Haematology, 108, 408 414.
2. Bortin, M.M., Truitt, R.L., Rimm, A.A. Bach, F.H. (1979) Graft-versus-leukemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature, 281, 490 491.
3. Diaz, M.A., Alegre, A., Villa, M., Benito, A., Bernardo, M.R., Lopez-Botet, M. Madero, L. (1997) Allogeneic peripheral blood progenitor cell (PBPC) transplantation in children with haematological malignancies. British Journal of Haematology, 96, 161 164.
4. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F. Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555 562.
5. Kim, Y.M., Mapara, M.Y., Down, J.D., Johnson, K.W., Boisgerault, F., Akiyama, Y., Benichou, G., Pelot, M., Zhao, G. Sykes, M. (2004) Graft-versus-host-reactive donor CD4 cells can induce T cell-mediated rejection of the donor marrow in mixed allogeneic chimeras prepared with nonmyeloablative conditioning. Blood, 103, 732 739.
6. Korngold, B. Sprent, J. (1978) Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. Journal of Experimental Medicine, 148, 1687 1698.
7. Mapara, M.Y., Kim, Y.M., Wang, S.-P., Bronson, R., Sachs, D.H. Sykes, M. (2002) Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood, 100, 1903 1909.
8. Mapara, M.Y., Kim, Y.M., Marx, J. Sykes, M. (2003) Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus- leukemia effects after conversion to full donor chimerism. Transplantation, 76, 297 305.
9. + cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed lymphocyte add-back. British Journal of Haematology, 115, 95 104.
10. Peggs, K.S., Thomson, K., Hart, D.P., Geary, J., Morris, E.C., Yong, K., Goldstone, A.H., Linch, D.C. Mackinnon, S. (2004) Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood, 103, 1548 1556.
11. Spitzer, T.R., McAfee, S., Sackstein, R., Colby, C., Toh, H.C., Multani, P., Saidman, S., Weyouth, D.W., Preffer, F., Poliquin, C., Foley, A., Cox, B., Andrews, D., Sachs, D.H. Sykes, M. (2000) Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biology of Blood and Marrow Transplantation, 6, 309 320.
12. + selected cells from peripheral blood from HLA-identical siblings. Blood, 97, 383 387.
13. Vicent, M.G., Madero, L., Ortega, J.J., Martinez, A., Gomez, P., Verdeguer, A., Badell, I., Muñoz, A., Olive, T., Maldonado, M.S., Bureo, E. Diaz, M.A. (2002) Matched-pair análisis comparting allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukaemia. Bone Marrow Transplantation, 30, 9 13.
14. Watanabe, T., Takaue, Y., Kawano, Y., Koike, K., Kikuta, A., Imaizumi, M., Watanabe, A., Eguchi, H., Ohta, S., Horikoshi, Y., Iwai, A., Makimoto, A. Kuroda, Y. (2002) HLA-Identical sibling peripheral blood stem cell transplantation in children and adolescents. Biology of Blood and Marrow Transplantation, 8, 26 31.